Skip to main
DHC
DHC logo

DHC Stock Forecast & Price Target

DHC Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 40%
Sell 40%
Strong Sell 0%

Bulls say

Diversified Healthcare Trust (DHC) exhibits a positive outlook primarily due to expected recovery in its SHOP segment, which is anticipated to generate improved operating results by the second half of 2024. The company is strategically focusing on optimizing its balance sheet through asset sales and refinancing initiatives that are projected to enhance liquidity and reduce debt costs. While annual funds from operations (AFFO) are expected to remain negative until at least 2025, a notable trend towards improvement may lead to a break-even point by 2026, underscoring a cautiously optimistic financial trajectory.

Bears say

Diversified Healthcare Trust faces significant risks stemming from general economic and regulatory trends, which could adversely affect the profitability of healthcare providers and impede the company's operational effectiveness in the evolving seniors housing market. The company's health is further compromised by an elevated net debt to EBITDA ratio of 10.2x, indicating high leverage that may constrain financial flexibility and resource allocation for necessary capital expenditure projects. Additionally, the recent transition of operators at approximately 50% of its senior housing communities may hinder the recovery of the SHOP segment, making it challenging for the company to navigate uncertainties moving forward.

DHC has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 40% suggest Holding, 40% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diversified Healthcare Trust and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diversified Healthcare Trust (DHC) Forecast

Analysts have given DHC a Hold based on their latest research and market trends.

According to 5 analysts, DHC has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diversified Healthcare Trust (DHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.